Literature DB >> 15670373

Treatment of pituitary adenomas with a transsphenoidal approach.

Xue-fei Shou1, Shi-qi Li, Yong-fei Wang, Yao Zhao, Pi-feng Jia, Liang-fu Zhou.   

Abstract

OBJECTIVE: To evaluate the overall therapeutic effectiveness of transsphenoidal microsurgery for pituitary adenomas and explore the surgical technique, application of new technology, and postoperative follow-up.
METHODS: The clinical presentation, imaging features, endocrine examination, pathological types, conditions of operation, postoperative complications, and follow-up of 4050 patients with pituitary adenomas who had undergone transsphenoidal microsurgery from December 1981 to January 2004 were analyzed retrospectively.
RESULTS: During the past 6 years, total tumor resection (under microscope) has been achieved in 97.3% of the patients with Hardy Grade I adenomas, 95.2% of Hardy Grade II, 90.4% of Hardy Grade III, and 47.4% of Hardy Grade IV. The percentages of total and subtotal resection achieved extended from 87.6% before 1987 to 96.9% in 2003.
CONCLUSION: With the improvement of microsurgical technique and application of novel technology, the indications for transsphenoidal microsurgery for pituitary adenomas were increasingly extended. We believe that more than 90% of pituitary adenomas could be treated by the transsphenoidal approach and totally removed through the microscope. The transnasal perpendicular plate-sphenoid sinus approach will be the dominant mode. Routine postoperative radiotherapy is not required for patients with total resection.

Entities:  

Mesh:

Year:  2005        PMID: 15670373     DOI: 10.1227/01.neu.0000147976.06937.1d

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  12 in total

Review 1.  Treatment of acromegaly: future.

Authors:  Ines Donangelo; Shlomo Melmed
Journal:  Endocrine       Date:  2005-10       Impact factor: 3.633

Review 2.  Back to the Egyptians: neurosurgery via the nose. A five-thousand year history and the recent contribution of the endoscope.

Authors:  Paolo Cappabianca; Enrico de Divitiis
Journal:  Neurosurg Rev       Date:  2006-08-30       Impact factor: 3.042

3.  Anatomy and CT reconstruction of the anterior area of sphenoid sinus.

Authors:  Shousen Wang; Jinchao Zhang; Liang Xue; Liangfeng Wei; Zhiyu Xi; Rumi Wang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

4.  Endoscopic endonasal transsphenoidal approach to sellar lesions: a detailed account of our mononostril technique.

Authors:  Stefan Linsler; Michael Robert Gaab; Joachim Oertel
Journal:  J Neurol Surg B Skull Base       Date:  2013-03-19

5.  Surgical management considerations in cystic prolactinomas-a single center case series.

Authors:  Edin Nevzati; Grégoire P Chatain; Steven B Carr; Kevin O Lillehei; Janice M Kerr
Journal:  Endocrine       Date:  2019-11-26       Impact factor: 3.633

6.  Surgical treatment for severe visual compromised patients after pituitary apoplexy.

Authors:  Chi-Cheng Chuang; Chen-Nen Chang; Kuo-Chen Wei; Cheng-Chih Liao; Peng-Wei Hsu; Ying-Cheng Huang; Yao-Liang Chen; Li-Ju Lai; Ping-Ching Pai
Journal:  J Neurooncol       Date:  2006-04-28       Impact factor: 4.130

7.  Microscopic surgery for pituitary adenomas to preserve the pituitary gland and stalk.

Authors:  Hao-Yu Li; Cheng-Yuan Feng; Chi Zhang; Jun Su; Jian Yuan; Yuanyang Xie; Yiwei Liao; Xianrui Yuan; Qing Liu
Journal:  Exp Ther Med       Date:  2017-01-19       Impact factor: 2.447

8.  Cons: endoscopic endonasal transsphenoidal pituitary surgery is not superior to microscopic transsphenoidal surgery for pituitary adenomas.

Authors:  Pietro Mortini
Journal:  Endocrine       Date:  2014-08-01       Impact factor: 3.633

9.  Microsurgical therapy of pituitary adenomas.

Authors:  Pietro Mortini; Lina Raffaella Barzaghi; Luigi Albano; Pietro Panni; Marco Losa
Journal:  Endocrine       Date:  2017-10-24       Impact factor: 3.633

Review 10.  Treatment of empty sella associated with visual impairment: a systematic review of chiasmapexy techniques.

Authors:  Lina Raffaella Barzaghi; Carmine Antonio Donofrio; Pietro Panni; Marco Losa; Pietro Mortini
Journal:  Pituitary       Date:  2018-02       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.